• Skip to main navigation
  • Skip to main content
  • Skip to Footer
  • Navigate Novartis
    • Patients
    • Healthcare Professionals
    • Media
    • Investors
    • Partners
    • ESG
    • Job Seekers
    • Clinical Trials
  • Coronavirus
  • Global
    • Novartis site directory
Novartis logo: a global healthcare company
  • Our Company
    • Our Leadership
      • Board of Directors
      • Executive Committee of Novartis
    • Our Approach
      • Strategy
      • Corporate Responsibility
      • Diversity & Inclusion
      • Partnering
      • People and Culture
    • Our Business
      • Global Product Portfolio
      • Innovative Medicines
      • Novartis Pharmaceuticals
      • Novartis Gene Therapies
      • Novartis Oncology
      • Sandoz
    • Media
      • Newsroom
      • News Archive
      • Multimedia Resources
      • Subscribe to Updates
    • Investors
      • Event Calendar
      • Financial Data
      • Share Data & Analysis
      • Shareholder Information
      • Environmental, Social & Governance
  • Our Focus
    • Disease Areas
      • Cancer
      • Cardiovascular, Renal and Metabolic Medicine
      • Immunology & Dermatology
      • Ophthalmology
      • Neuroscience
      • Respiratory
    • Platforms and Technology
      • Data and Digital
      • Cell & Gene Therapy
    • Novartis Stories
      • Discovery
      • From Our Labs
      • Access to Healthcare
      • Patient Perspectives
      • People and Culture
      • Live Magazine
  • Our Impact
    • Building Trust with Society
      • Corporate Responsibility
      • Ethical Standards
      • Access
      • Environmental Sustainability
    • Global Health
      • Malaria
      • Sickle Cell Disease
      • Chagas disease
      • Leprosy
      • Novartis Foundation
    • ESG Performance and Reporting
      • Materiality Assessment
      • Environmental, Social and Governance
      • Transparency and Disclosures
      • Positions on Key Topics
      • Statements on Key Issues
  • Our Science
    • Research & Early Development
      • Novartis Institutes for BioMedical Research
      • Research Disease Areas
      • Postdoc Program
      • Open Source Science
    • Drug Development at Novartis
      • Novartis Pipeline
      • Clinical Trials
      • Translational Medicine
      • Global Product Portfolio
    • Science Stories
      • Discovery
      • From Our Labs
  • Careers
    • Your Career
      • Global Career Search
      • Teams and Skills
      • Gene Therapies Careers
    • Working at Novartis
      • Diversity & Inclusion
      • People and Culture
      • Corporate Responsibility
    • Career Programs
      • Our Career Programs
      • Students and Scholars
      • Novartis Quantitative Sciences Hackathon
Search
President of Advanced Accelerator Applications shares her story for “Women in Science.”
  • TwitterTweet
  • FacebookShare
  • Share
    • Twitter
    • Facebook
    • LinkedIn
    • Email
    • Whatsapp
  • Jump to Comments
Stories/Discovery

Women in Science: Susanne Schaffert

Susanne Schaffert, President of Advanced Accelerator Applications, describes her career in science.

Dec 12, 2018

Susanne Schaffert discusses her career in science.

We recently chatted with Susanne Schaffert, president of Advanced Accelerator Applications (AAA). AAA, a radiopharmaceutical company acquired by Novartis, is developing innovative technologies that have the potential to radically transform health care and impact the lives of patients. In this latest installment of “Novartis Presents: Women in Science,” Schaffert describes her work at AAA and the evolution of her career.

When did you first know you wanted to work in science?

When I was finishing up school, I had a love for the arts and creativity but was always fascinated by innovation. It was the realization that science is where you can make an impact on daily lives – something that is so important to me. For example, chemistry impacts your day from the moment you start brushing your teeth!

Tell us about your career evolution.

I received my Ph.D. in chemistry and ultimately began my career in the lab. It was there that I realized I was passionate about science, but I wanted to be able to connect what I was doing with other aspects of the industry and make a difference in people’s lives.

My first venture into business was a role in marketing, where I led the oncology business in Germany. From there, I chose various roles that were focused in science and marketing and gave me increased responsibility. For example, I took a role as head of investor relations, where it really helped that I understood the science and could explain the innovation and its importance to our investors.

Tell us about the transition to AAA and what excites you about it.

The new innovative scientific platform that AAA has created is what thrills me. We are working on different and exciting things in oncology like combinations of diagnostics and therapeutics, creating new approaches in patient management, and creating unique ways for physicians to visualize and treat tumors. We are more than 650 people strong at AAA, inclusive of researchers and scientists, and we continue to grow.

Schaffert visiting AAA’s manufacturing site in Millburn, New Jersey, in the US
Schaffert visiting AAA’s manufacturing site in Millburn, New Jersey, in the US

What is your advice for young women interested in science?

Stay curious! There are constant advances in science and technology – especially in the last 5 years – so if you keep learning and continue to be open-minded, you can continue to make an impact.

Also, it’s really about networking. It’s important to build bridges and know who you can tap into to help you solve a particular problem. When I look at when I started my studies in chemistry, 10% of females were in the class and only 5% of them actually finished. Now, I’m seeing more women getting involved and taking opportunities in science – and that encourages me because diversity is so important in a team to drive different thinking and innovation.

What is your favorite part of your job at Novartis?

Definitely the people. I think the privilege we have working in health care is that you are surrounded by supersmart people who are talented and passionate. I love driving solutions for patients, and I feel privileged to work with my team.

I love working in an environment where the ultimate goal is serving patients. First and foremost, my team has the passion to impact and change patients’ lives.

What is the most challenging part?

The biggest challenge in this industry is maintaining the right balance between moving fast to innovate and meet the needs of our patients and ensuring that we are operating at the highest standards of quality and compliance. Both are essential to achieving success, and as a leader, it is up to you to keep the equilibrium throughout the organization.  

What types of qualities do you look for in talent?

There are a few things that I look for, but especially in health care, people need to have a passion for helping patients. That is our ultimate purpose as employees in oncology. That passion drives us to do our best every day. 

Other great qualities include being resilient and persistent. Business and science can be tough and you will face many challenges, but believing in your dreams and not giving up is very important in order to develop successfully in your career. Accept that the business includes failures and that only helps you succeed in the end.

Schaffert with other attendees after a speech at a women’s leadership program
Schaffert with other attendees after a speech at a women’s leadership program.

“Novartis Presents: Women in Science” is an ongoing series showcasing women at Novartis who are helping develop innovative oncology medicines for people with cancer and related diseases.

Shareline

Susanne Schaffert is president of Advanced Accelerator Applications and one of our #WomenInScience
Tweet Tweetpopo
Tags: 
Oncology, Women in Science, Working at Novartis, Reimagine Medicine, Careers
Disclaimer: 

Responses have been edited for length.
 

    • TwitterTweet
    • FacebookShare
    • Share
      • Twitter
      • Facebook
      • LinkedIn
      • Email
      • Whatsapp
    • Jump to Comments
  • Print
  • Save

Novartis Stories

View all

RNA strand
Discovery

Take a visual tour of medicines that target RNA

A kidney patient is smiling at the camera
Discovery

New hope for treating inflammatory diseases of the kidney

2D rendering of kidneys
Discovery

Predictive analytics could bring medicines to patients faster

You are here

  1. Home ›
  2. Stories ›
  3. Discovery

Novartis Global

  • Navigate Novartis

    • Patients & Caregivers
    • Healthcare Professionals
    • Investors
    • Media
    • Society & ESG
    • Partners
  • Contact Us

    • Global Contacts
    • Office Locations
    • For Investors
    • For Media
  • About Novartis

    • Our Company
    • Our Focus
    • Our Impact
    • Our Science
    • Our Stories
  • Our Portfolio

    • Global Product Portfolio
    • Global Clinical Pipeline
  • Careers

    • Career Search

Connect with Novartis

  • twitter
  • linkedin
  • youtube
  • facebook
  • instagram
Novartis Site Directory
© 2021 Novartis AG
  • Terms of Use
  • Privacy Policy
  • Contact Us
  • Site Map
  • Cookie Settings

This site is intended for a global audience.